Related references
Note: Only part of the references are listed.Advances in the Physiology of GPR55 in the Central Nervous System
Bruno A. Marichal-Cancino et al.
CURRENT NEUROPHARMACOLOGY (2017)
High fat diet induced-obesity facilitates anxiety-like behaviors due to GABAergic impairment within the dorsomedial hypothalamus in rats
Sylvana Rendeiro de Noronha et al.
BEHAVIOURAL BRAIN RESEARCH (2017)
The cannabinoid CB1 receptor and mTORC1 signalling pathways interact to modulate glucose homeostasis in mice
Francisco J. Bermudez-Silva et al.
DISEASE MODELS & MECHANISMS (2016)
Deletion of G-protein-coupled receptor 55 promotes obesity by reducing physical activity
A. Meadows et al.
INTERNATIONAL JOURNAL OF OBESITY (2016)
Human CB1 Receptor Isoforms, present in Hepatocytes and β-cells, are Involved in Regulating Metabolism
Isabel Gonzalez-Mariscal et al.
SCIENTIFIC REPORTS (2016)
Endocannabinoid System Contributes to Liver Injury and Inflammation by Activation of Bone Marrow-Derived Monocytes/Macrophages in a CB1-Dependent Manner
Ping Mai et al.
JOURNAL OF IMMUNOLOGY (2015)
Heteromerization of GPR55 and cannabinoid CB2 receptors modulates signalling
N. A. Balenga et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
CB1 and GPR55 receptors are co-expressed and form heteromers in rat and monkey striatum
E. Martinez-Pinilla et al.
EXPERIMENTAL NEUROLOGY (2014)
Regulation of GPR55 in rat white adipose tissue and serum LPI by nutritional status, gestation, gender and pituitary factors
Monica Imbernon et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
Peripheral selectivity of the novel cannabinoid receptor antagonist TM38837 in healthy subjects
Linda E. Klumpers et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Diet-induced obesity promotes depressive-like behaviour that is associated with neural adaptations in brain reward circuitry
S. Sharma et al.
INTERNATIONAL JOURNAL OF OBESITY (2013)
Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes
Tony Jourdan et al.
NATURE MEDICINE (2013)
Anti-obesity efficacy of LH-21, a cannabinoid CB1 receptor antagonist with poor brain penetration, in diet-induced obese rats
Monica Alonso et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Peripheral Cannabinoid-1 Receptor Inverse Agonism Reduces Obesity by Reversing Leptin Resistance
Joseph Tam et al.
CELL METABOLISM (2012)
The L-α-Lysophosphatidylinositol/GPR55 System and Its Potential Role in Human Obesity
Jose Maria Moreno-Navarrete et al.
DIABETES (2012)
Modulation of L-α-Lysophosphatidylinositol/GPR55 Mitogen-activated Protein Kinase (MAPK) Signaling by Cannabinoids
Sharon Anavi-Goffer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans
Silvana Y. Romero-Zerbo et al.
JOURNAL OF ENDOCRINOLOGY (2011)
Minireview: Recent Developments in the Physiology and Pathology of the Lysophosphatidylinositol-Sensitive Receptor GPR55
Christopher M. Henstridge et al.
MOLECULAR ENDOCRINOLOGY (2011)
Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity
Joseph Tam et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
The endocannabinoid system, eating behavior and energy homeostasis: The end or a new beginning?
F. J. Bermudez-Silva et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2010)
CB1 antagonists for obesity-what lessons have we learned from rimonabant?
Vincenzo Di Marzo et al.
NATURE REVIEWS ENDOCRINOLOGY (2009)
Should peripheral CB1 cannabinoid receptors be selectively targeted for therapeutic gain?
George Kunos et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Peripheral, but Not Central, CB1 Antagonism Provides Food Intake-Independent Metabolic Benefits Diet-Induced Obese Rats
Ruben Nogueiras et al.
DIABETES (2008)
Pharmacological evaluation of LH-21, a newly discovered molecule that binds to cannabinoid CB1 receptor
Richard Z. Chen et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Central versus peripheral antagonism of cannabinoid CB1 receptor in obesity:: Effects of LH-21, a peripherally acting neutral cannabinoid receptor antagonist, in Zucker rats
F. J. Pavon et al.
JOURNAL OF NEUROENDOCRINOLOGY (2008)
Obesity and mental disorders in the general population: results from the world mental health surveys
K. M. Scott et al.
INTERNATIONAL JOURNAL OF OBESITY (2008)
Diet-induced obesity causes severe but reversible leptin resistance in arcuate melanocortin neurons
Pablo J. Enriori et al.
CELL METABOLISM (2007)
Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity
Matthias Blueher et al.
DIABETES (2006)
Antiobesity effects of the novel in vivo neutral cannabinoid receptor antagonist 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole-LH 21
Francisco Javier Pavon et al.
NEUROPHARMACOLOGY (2006)
Regulation, function, and dysregulation of endocannabinoids in models of adipose and β-pancreatic cells and in obesity and hyperglycemia
Isabel Matias et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Activation of the peripheral endocannabinoid system in human obesity
S Engeli et al.
DIABETES (2005)
Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse: physiological and molecular characteristics
S Collins et al.
PHYSIOLOGY & BEHAVIOR (2004)
Discovery of 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole, a novel in vivo cannabinoid antagonist containing a 1,2,4-triazole motif
N Jagerovic et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Share Paper
